湿疹の世界市場レポート 2025

湿疹市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.1％で243億5,000万米ドルに成長します。予測期間中の成長は、アトピー性皮膚炎治療需要の高まり、業務活動の増加、湿疹の認知度向上、生物学的製剤の使用拡大、遠隔医療プラットフォームの採用拡大などに起因すると考えられます。予測期間における主な動向としては、戦略的提携、新たな治療法の開発、注射薬の台頭、個別化医療の進展などが挙げられます。

自己免疫疾患の有病率の上昇は、今後数年間の湿疹市場の拡大を促進すると予想されます。自己免疫疾患は、身体の免疫系が誤って健康な細胞や組織、臓器を攻撃し、炎症や損傷を引き起こすことで発生します。これらの疾患の罹患率の増加は、遺伝的感受性、環境要因、感染症、食生活の変化、ストレスや汚染物質への暴露などのライフスタイルの影響と関連しています。乾癬、ループス、関節リウマチなどの自己免疫疾患は、免疫反応の異常と関連しており、湿疹やその他の炎症性皮膚疾患の可能性を高めています。例えば、2024年11月、ドイツを拠点とする組織であるVersorgungsatlas.deは、2022年に7,324万1,305人の被保険者のうち、630万4,340人が少なくとも1つの自己免疫疾患と診断されたと報告しました。その結果、自己免疫疾患の有病率の増加が湿疹市場の成長に拍車をかけています。

湿疹市場の主要企業は、治療効果を向上させ、専門的なスキンケアソリューションに対する需要の高まりに対応するため、先進的な湿疹ケアクリームなどの革新的な製品の開発に注力しています。湿疹ケアクリームは、患部の皮膚を落ち着かせ、潤いを与え、保護し、かゆみ、炎症、乾燥を軽減するよう処方されています。例えば、2024年9月、英国のパーソナルケアブランドであるDove社は、Baby Dove湿疹Care Soothing Bath TreatmentとBaby Dove湿疹Care Creamを含む乳幼児用の新しい湿疹ケアシリーズを発売しました。この製品ラインは、湿疹を持つ乳幼児のために特別に設計され、敏感な肌への優しさを保証するために、100％肌天然の栄養素を特徴としています。さらに、コロイドオートミール（1.0％）を配合し、肌荒れを和らげ、肌のうるおいを保つ重要な成分として知られています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界湿疹PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の湿疹市場：成長率分析
• 世界の湿疹市場の実績：規模と成長, 2019-2024
• 世界の湿疹市場の予測：規模と成長, 2024-2029, 2034F
• 世界湿疹総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の湿疹市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アトピー性皮膚炎
• 接触性皮膚炎
• 脂漏性皮膚炎
• その他のタイプ
• 世界の湿疹市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所治療
• 経口薬
• 生物学的製剤
• 光線療法
• 世界の湿疹市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 子供たち
• 大人
• お年寄り
• 世界の湿疹市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院または診療所
• 皮膚科センター
• ホームケア
• 薬局
• 世界の湿疹市場アトピー性皮膚炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所ステロイド
• 局所カルシニューリン阻害剤
• 保湿剤
• 生物学的療法
• 世界の湿疹市場接触性皮膚炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所ステロイド
• 抗ヒスタミン薬
• 局所免疫抑制剤
• 湿布
• 世界の湿疹市場脂漏性皮膚炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗真菌クリームまたはシャンプー
• 局所ステロイド
• 薬用シャンプー
• 局所カルシニューリン阻害剤
• 世界の湿疹市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アレルギー性皮膚炎
• 貨幣状皮膚炎
• 神経性皮膚炎
• 汗疱性異汗症湿疹

第7章 地域別・国別分析

• 世界の湿疹市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の湿疹市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 湿疹市場：競合情勢
• 湿疹市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbieVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca PLC
• Novartis AG
• GlaxoSmithKline plc
• Amgen
• Hoffmann-La Roche AG
• Eli Lilly and Co.
• Siemens Healthineers AG
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc
• Bausch Health Companies Inc.
• Galderma
• Cadila Pharmaceuticals Ltd.
• LEO Pharma A/S

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 湿疹市場2029：新たな機会を提供する国
• 湿疹市場2029：新たな機会を提供するセグメント
• 湿疹市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Eczema is a chronic inflammatory skin condition marked by redness, itching, dryness, and irritation. It results from a combination of genetic and environmental factors, leading to a weakened skin barrier and an overactive immune response. While eczema can affect individuals of all ages, it is more common in children. The condition often occurs in flare-ups triggered by allergens, irritants, stress, or climate changes.

The primary types of eczema include atopic dermatitis, contact dermatitis, seborrheic dermatitis, and other variations. Atopic dermatitis, commonly referred to as eczema, is a chronic skin disorder characterized by itchy, red, and inflamed skin, often aggravated by allergens, irritants, or stress. Treatment options for eczema include topical treatments, oral medications, biologics, and phototherapy. The condition affects various age groups, including children, adults, and the elderly, and is managed across different healthcare settings such as hospitals, clinics, dermatology centers, home care, and pharmacies.

The eczema market research report is one of a series of new reports from The Business Research Company that provides eczema market statistics, including the eczema industry global market size, regional shares, competitors with the eczema market share, detailed eczema market segments, market trends, and opportunities, and any further data you may need to thrive in the eczema industry. This eczema market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The eczema market size has grown strongly in recent years. It will grow from $16.41 billion in 2024 to $17.81 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the increasing prevalence of autoimmune diseases, the rising cases of eczema, greater regulatory approvals, the growing incidence of air pollution, and the increasing burden of allergic reactions.

The eczema market size is expected to see strong growth in the next few years. It will grow to $24.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth during the forecast period can be attributed to the rising demand for atopic dermatitis treatment, increasing operational activities, greater awareness of eczema, the growing use of biologics, and the expanding adoption of telemedicine platforms. Key trends in the forecast period include strategic collaborations, the development of emerging therapies, the rise of injectable drugs, and the advancement of personalized medicine.

The rising prevalence of autoimmune disorders is expected to drive the expansion of the eczema market in the coming years. Autoimmune disorders occur when the body's immune system mistakenly attacks healthy cells, tissues, or organs, leading to inflammation and damage. The growing incidence of these conditions is linked to genetic susceptibility, environmental factors, infections, dietary changes, and lifestyle influences such as stress and exposure to pollutants. Autoimmune diseases such as psoriasis, lupus, and rheumatoid arthritis are associated with dysregulated immune responses, increasing the likelihood of eczema and other inflammatory skin conditions. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. Consequently, the increasing prevalence of autoimmune disorders is fueling the growth of the eczema market.

Leading companies in the eczema market are focusing on developing innovative products, such as advanced eczema care creams, to improve treatment effectiveness and meet the growing demand for specialized skincare solutions. Eczema care creams are formulated to soothe, hydrate, and protect affected skin, reducing itching, inflammation, and dryness. For instance, in September 2024, Dove, a UK-based personal care brand, launched a new Eczema Care range for babies, including the Baby Dove Eczema Care Soothing Bath Treatment and the Baby Dove Eczema Care Cream. This product line is designed specifically for infants with eczema, featuring 100% skin-natural nutrients to ensure gentleness on sensitive skin. Additionally, the formulations contain colloidal oatmeal (1.0%), a key ingredient known for soothing irritation and maintaining skin moisture.

In May 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Proteologix Inc. for approximately $850 million. This acquisition aims to strengthen Johnson & Johnson's position in treating atopic dermatitis (AD) and asthma by integrating innovative bispecific antibody therapies into its product portfolio. Proteologix Inc. is a US-based biotechnology company specializing in the development of bispecific antibodies for immune-mediated diseases.

Major players in the eczema market are Pfizer Inc., AbbieVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Amgen, Hoffmann-La Roche AG, Eli Lilly and Co., Siemens Healthineers AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc, Bausch Health Companies Inc., Galderma, Cadila Pharmaceuticals Ltd., LEO Pharma A/S, Almirall, Kyowa Kirin, Alliance Pharma Plc, Encore Dermatology Inc., Arcutis Inc.

North America was the largest region in the eczema market in 2024. The regions covered in eczema report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the eczema market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The eczema market consists of revenues earned by entities by providing services such as diagnosis and consultation services, prescription and medication services, phototherapy services, allergy testing and immunotherapy, and skin barrier repair therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The eczema market also includes sales of antihistamines, topical corticosteroids, calcineurin inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Eczema Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on eczema market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for eczema ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The eczema market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Atopic Dermatitis; Contact Dermatitis; Seborrheic Dermatitis; Other Types
• 2) By Treatment Type: Topical Treatments; Oral Medications; Biologics; Phototherapy
• 3) By Age Group: Children; Adults; Elderly
• 4) By End User: Hospitals Or Clinics; Dermatology Centers; Home Care; Pharmacies
• Subsegments:
• 1) By Atopic Dermatitis: Topical Steroids; Topical Calcineurin Inhibitors; Moisturizers; Biologic Therapies
• 2) By Contact Dermatitis: Topical Steroids; Antihistamines; Topical Immunosuppressants; Wet Compresses
• 3) By Seborrheic Dermatitis: Antifungal Creams or Shampoos; Topical Steroids; Medicated Shampoos; Topical Calcineurin Inhibitors
• 4) By Other Types: Allergic Dermatitis; Nummular Dermatitis; Neurodermatitis; Dyshidrotic Eczema
• Companies Mentioned: Pfizer Inc.; AbbieVie Inc.; Bayer AG; Sanofi S.A; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Eczema Market Characteristics

3. Eczema Market Trends And Strategies

4. Eczema Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Eczema Growth Analysis And Strategic Analysis Framework

• 5.1. Global Eczema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Eczema Market Growth Rate Analysis
• 5.4. Global Eczema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Eczema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Eczema Total Addressable Market (TAM)

6. Eczema Market Segmentation

• 6.1. Global Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Atopic Dermatitis
• Contact Dermatitis
• Seborrheic Dermatitis
• Other Types
• 6.2. Global Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Treatments
• Oral Medications
• Biologics
• Phototherapy
• 6.3. Global Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Children
• Adults
• Elderly
• 6.4. Global Eczema Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Or Clinics
• Dermatology Centers
• Home Care
• Pharmacies
• 6.5. Global Eczema Market, Sub-Segmentation Of Atopic Dermatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Steroids
• Topical Calcineurin Inhibitors
• Moisturizers
• Biologic Therapies
• 6.6. Global Eczema Market, Sub-Segmentation Of Contact Dermatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Steroids
• Antihistamines
• Topical Immunosuppressants
• Wet Compresses
• 6.7. Global Eczema Market, Sub-Segmentation Of Seborrheic Dermatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antifungal Creams or Shampoos
• Topical Steroids
• Medicated Shampoos
• Topical Calcineurin Inhibitors
• 6.8. Global Eczema Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergic Dermatitis
• Nummular Dermatitis
• Neurodermatitis
• Dyshidrotic Eczema

7. Eczema Market Regional And Country Analysis

• 7.1. Global Eczema Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Eczema Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Eczema Market

• 8.1. Asia-Pacific Eczema Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Eczema Market

• 9.1. China Eczema Market Overview
• 9.2. China Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Eczema Market

• 10.1. India Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Eczema Market

• 11.1. Japan Eczema Market Overview
• 11.2. Japan Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Eczema Market

• 12.1. Australia Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Eczema Market

• 13.1. Indonesia Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Eczema Market

• 14.1. South Korea Eczema Market Overview
• 14.2. South Korea Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Eczema Market

• 15.1. Western Europe Eczema Market Overview
• 15.2. Western Europe Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Eczema Market

• 16.1. UK Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Eczema Market

• 17.1. Germany Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Eczema Market

• 18.1. France Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Eczema Market

• 19.1. Italy Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Eczema Market

• 20.1. Spain Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Eczema Market

• 21.1. Eastern Europe Eczema Market Overview
• 21.2. Eastern Europe Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Eczema Market

• 22.1. Russia Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Eczema Market

• 23.1. North America Eczema Market Overview
• 23.2. North America Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Eczema Market

• 24.1. USA Eczema Market Overview
• 24.2. USA Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Eczema Market

• 25.1. Canada Eczema Market Overview
• 25.2. Canada Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Eczema Market

• 26.1. South America Eczema Market Overview
• 26.2. South America Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Eczema Market

• 27.1. Brazil Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Eczema Market

• 28.1. Middle East Eczema Market Overview
• 28.2. Middle East Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Eczema Market

• 29.1. Africa Eczema Market Overview
• 29.2. Africa Eczema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Eczema Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Eczema Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Eczema Market Competitive Landscape And Company Profiles

• 30.1. Eczema Market Competitive Landscape
• 30.2. Eczema Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbieVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Eczema Market Other Major And Innovative Companies

• 31.1. AstraZeneca PLC
• 31.2. Novartis AG
• 31.3. GlaxoSmithKline plc
• 31.4. Amgen
• 31.5. Hoffmann-La Roche AG
• 31.6. Eli Lilly and Co.
• 31.7. Siemens Healthineers AG
• 31.8. Viatris Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Regeneron Pharmaceuticals Inc.
• 31.11. Astellas Pharma Inc
• 31.12. Bausch Health Companies Inc.
• 31.13. Galderma
• 31.14. Cadila Pharmaceuticals Ltd.
• 31.15. LEO Pharma A/S

32. Global Eczema Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Eczema Market

34. Recent Developments In The Eczema Market

35. Eczema Market High Potential Countries, Segments and Strategies

• 35.1 Eczema Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Eczema Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Eczema Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer